Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01600885 · ClinicalTrials.gov registry record · NA
The Effects of Ketamine and Guanfacine on Working Memory in Healthy Subjects
A NA study, sponsored by Yale University.
- Completed
- Registry status
- NA
- Development phase
- 16
- Enrollment target
NCT01600885 is a NA study that has completed, run by Yale University. The registered enrollment target is 16 participants.
The verdict
NCT01600885, a NA study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- NA
- Development phase
- 16 participants
- Enrollment target
Study Summary
The purpose of the study is 1. To establish the feasibility of fMRI studies of the interaction of guanfacine and ketamine. 2. To explore the possibility that guanfacine can ameliorate the negative effects of ketamine on task-related prefrontal activation. 3. To assess the strength of any interaction between guanfacine and ketamine.
Interventions
- DRUG Placebo
- DRUG Guanfacine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2008-08 |
| Est. Completion | 2014-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01600885
The ClinicalTrials.gov registry entry for NCT01600885 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01600885 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01600885 about?
NCT01600885 is a clinical study titled "The Effects of Ketamine and Guanfacine on Working Memory in Healthy Subjects". The purpose of the study is 1. To establish the feasibility of fMRI studies of the interaction of guanfacine and ketamine. 2. To explore the possibility that guanfacine can ameliorate the negative effects of ketamine on task-related prefrontal activation. 3. To assess the strength of any interactio...
What is the current status of trial NCT01600885?
This trial is currently completed. It is a NA study. The enrollment target is 16 participants. The study started on 2008-08. Estimated completion is 2014-12.
What interventions are being tested in trial NCT01600885?
The interventions under investigation include: Placebo (DRUG), Guanfacine (DRUG).
Who is sponsoring clinical trial NCT01600885?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.